AlloStim Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: This is a single center, open label dose frequency escalation study of CryoVax. personalized anti-tumor vaccine protocol combining the cryoablation of a selected metastatic lesion with intra-lesional immunotherapy with AlloStim. The in-situ (in the body) cancer vaccine step combines killing a single metastatic tumor lesion by use of cryoablation in order to cause the release of tumor-specific markers to the immune system and then injecting bioengineered allogeneic immune cells (AlloStim) into the lesion as an adjuvant in order to modulate the immune response and educate the immune system to kill other tumor cells where ever they reside in the body.
DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Colorectal Cancer Metastatic
PROVIDER: 2185135 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA